Track Syn‑Ake in Peptimes™
Syn-Ake is dipeptide diaminobutyroyl benzylamide diacetate: beta-alanyl-L-prolyl-2,4-diaminobutyric acid benzylamide, as its diacetate salt. FDA's substance registry lists it under both names. (Source: FDA's substance registry (GSRS).)
Is Syn-Ake FDA-approved?
No. Syn-Ake isn't FDA-approved, and Drugs@FDA lists no application with it as an active ingredient.
Syn-Ake
Also: dipeptide diaminobutyroyl benzylamide diacetate, Synake, DABBA, H-beta-Ala-Pro-Dab-NH-Bzl
- Status label in the Peptimes Library
- Not FDA-Approved
- Routes in Peptimes
- Topical
- Updated
- 1 Nov 2026
US regulatory status
What studies have looked at
Each point says who or what was studied and what the study reported, with its source and the date we checked it. These are findings from the sources cited, not advice or a promise of any result.
- Review of studies
A 2020 review of cosmetic peptides found no published scientific papers describing clinical studies of Syn-Ake. The wrinkle figures it reports for Syn-Ake come from the manufacturer.
Source: PMID 33195061, checked 1 Nov 2026
How to track it in Peptimes
Add Syn-Ake in My Protocols and set the schedule you already follow: days of the week, times of day and a start date. Peptimes never suggests an amount when you log or schedule a dose. Its Library entry shows the status label “Not FDA-Approved”.
- Logging: the amount you applied and how you feel. It’s logged as topical, so there’s no injection site to record.
- Reminders and history: reminders at your times, Dose History, the Calendar and CSV or JSON export work as described on the peptide tracker app page.
Peptimes is a tracking app, not medical advice. Talk to a licensed clinician about your treatment. Peptimes doesn’t sell Syn-Ake or any other compound.
More sources
- FDA, Global Substance Registration System, Dipeptide diaminobutyroyl benzylamide diacetate, checked 1 Nov 2026: its structure and the name Syn-Ake.
- Errante and others, Frontiers in Chemistry, 2020, Cosmeceutical Peptides in the Framework of Sustainable Wellness Economy, full text checked 1 Nov 2026: Syn-Ake as a cosmetic peptide, and no published clinical studies of it.